These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21577228)

  • 1. Kinetics of ocular and systemic antigen-specific T-cell responses elicited during murine cytomegalovirus retinitis.
    Zinkernagel MS; Petitjean C; Wikstrom ME; Degli-Esposti MA
    Immunol Cell Biol; 2012 Mar; 90(3):330-6. PubMed ID: 21577228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-2 immunotherapy of murine cytomegalovirus retinitis during MAIDS correlates with increased intraocular CD8+ T-cell infiltration.
    Dix RD; Cousins SW
    Ophthalmic Res; 2003; 35(3):154-9. PubMed ID: 12711843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection.
    Munks MW; Pinto AK; Doom CM; Hill AB
    J Immunol; 2007 Jun; 178(11):7235-41. PubMed ID: 17513772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraocular viral replication after systemic murine cytomegalovirus infection requires immunosuppression.
    Gao EK; Yu XH; Lin CP; Zhang H; Kaplan HJ
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2322-7. PubMed ID: 7558728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Four distinct patterns of memory CD8 T cell responses to chronic murine cytomegalovirus infection.
    Munks MW; Cho KS; Pinto AK; Sierro S; Klenerman P; Hill AB
    J Immunol; 2006 Jul; 177(1):450-8. PubMed ID: 16785542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and outer blood-retina barrier (BRB) compromise following choroidal murine cytomegalovirus (MCMV) infections.
    Xu J; Liu X; Mo J; Marshall B; Perry L; Dong Z; Zhang M
    Mol Vis; 2018; 24():379-394. PubMed ID: 29853772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.
    Çuburu N; Bialkowski L; Pontejo SM; Sethi SK; Bell ATF; Kim R; Thompson CD; Lowy DR; Schiller JT
    Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2116738119. PubMed ID: 35749366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple epitopes in the murine cytomegalovirus early gene product M84 are efficiently presented in infected primary macrophages and contribute to strong CD8+-T-lymphocyte responses and protection following DNA immunization.
    Ye M; Morello CS; Spector DH
    J Virol; 2004 Oct; 78(20):11233-45. PubMed ID: 15452242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cytomegalovirus-based vaccine expressing a single tumor-specific CD8+ T-cell epitope delays tumor growth in a murine model of prostate cancer.
    Klyushnenkova EN; Kouiavskaia DV; Parkins CJ; Caposio P; Botto S; Alexander RB; Jarvis MA
    J Immunother; 2012 Jun; 35(5):390-9. PubMed ID: 22576344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of the perforin cytotoxic pathway predisposes mice to experimental cytomegalovirus retinitis.
    Dix RD; Podack ER; Cousins SW
    J Virol; 2003 Mar; 77(6):3402-8. PubMed ID: 12610115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor of Cytokine Signaling 1 (SOCS1) and SOCS3 Are Stimulated within the Eye during Experimental Murine Cytomegalovirus Retinitis in Mice with Retrovirus-Induced Immunosuppression.
    Chien H; Alston CI; Dix RD
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell modulation of murine cytomegalovirus retinitis.
    Bigger JE; Thomas CA; Atherton SS
    J Immunol; 1998 Jun; 160(12):5826-31. PubMed ID: 9637493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination.
    Holtappels R; Simon CO; Munks MW; Thomas D; Deegen P; Kühnapfel B; Däubner T; Emde SF; Podlech J; Grzimek NK; Oehrlein-Karpi SA; Hill AB; Reddehase MJ
    J Virol; 2008 Jun; 82(12):5781-96. PubMed ID: 18367531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
    Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
    J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice immunosuppressed by murine retrovirus infection (MAIDS) are susceptible to cytomegalovirus retinitis.
    Dix RD; Cray C; Cousins SW
    Curr Eye Res; 1994 Aug; 13(8):587-95. PubMed ID: 7956311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E; Tan QX; Sharp M; Girling V; Poon C; Natta MV; Jabs DA; Inokuma M; Maecker HT; Bredt B; Jacobson MA;
    J Infect Dis; 2006 Dec; 194(11):1537-46. PubMed ID: 17083038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of ocular MCMV infection.
    Zinkernagel MS; Petitjean C; Fleming P; Chinnery HR; Constable IJ; McMenamin PG; Degli-Esposti MA
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):369-74. PubMed ID: 19684003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal CD8
    Dimonte S; Gimeno-Brias S; Marsden M; Chapman L; Sabberwal P; Clement M; Humphreys IR
    Immunology; 2021 Oct; 164(2):279-291. PubMed ID: 34003499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular reactivation of MCMV after immunosuppression of latently infected BALB/c mice.
    Zhang M; Xin H; Duan Y; Atherton SS
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):252-8. PubMed ID: 15623781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional characterization of CD8(+) T cell clones specific for a mouse cytomegalovirus epitope.
    Fernandez JA; Zavala F; Tsuji M
    Virology; 1999 Mar; 255(1):40-9. PubMed ID: 10049820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.